OTC Markets Group Welcomes Repro Med Systems to OTCQX

NEW YORK, Sept. 18, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Repro Med Systems, Inc. (OTCQX: REPR), a manufacturer of medical devices for the ambulatory infusion market, has qualified to trade on the OTCQX® Best Market. 

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

Repro Med begins trading today on OTCQX under the symbol "REPR."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"We are pleased to welcome Repro Med to the family of established, global and growth companies on our OTCQX market," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "OTCQX provides a transparent public trading market for growing companies like Repro Med that are committed to maintaining high-quality financial and operating standards.  We look forward to supporting Repro Med in its continued growth as a publicly-traded company."

Andrew Sealfon, President of Repro Med Systems, commented, "Our focus on building our core business is bearing gratifying results in building value for our shareholders.  Qualifying for trading on OTCQX is an important step in fulfilling our commitments to transparency and compliance.  It is also an important foundation for executing our long term strategy for product line expansion and profitable sales growth."

Salon Marrow Dyckman Newman & Broudy LLP serves as Repro Med's Designated Advisor for Disclosure ("DAD") on OTCQX, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.

Repro Med designs, manufactures and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications to be sold domestically and internationally.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Media Contact:

Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-repro-med-systems-to-otcqx-300145192.html

SOURCE OTC Markets Group Inc.